Cargando…

Immune-Based Approaches for the Treatment of Pediatric Malignancies

Immune-based therapies have now been credentialed for pediatric cancers with the robust efficacy of chimeric antigen receptor (CAR) T cells for pediatric B cell acute lymphocytic leukemia (ALL), offering a chance of a cure for children with previously lethal disease and a potentially more targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosse, Kristopher R., Majzner, Robbie G., Mackall, Crystal L., Maris, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189419/ https://www.ncbi.nlm.nih.gov/pubmed/34113750 http://dx.doi.org/10.1146/annurev-cancerbio-030419-033436

Ejemplares similares

IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS
por: Foster, Jessica, et al.
Publicado: (2021)

Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report
por: Schultz, Liora, et al.
Publicado: (2020)

Immunotherapy Targets in Pediatric Cancer
por: Orentas, Rimas J., et al.
Publicado: (2012)

Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Potent antitumor efficacy of anti-GD2 CAR T-cells in H3K27M+ diffuse midline gliomas
por: Mount, Christopher W., et al.
Publicado: (2018)

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
por: Orentas, Rimas J, et al.
Publicado: (2013)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

Molecular Alterations in Pediatric Sarcomas: Potential Targets for Immunotherapy
por: Goletz, Theresa J., et al.
Publicado: (1998)

In Search of Targeted Therapies for Childhood Cancer
por: Mackall, Crystal L.
Publicado: (2011)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity
por: Richards, Rebecca M., et al.
Publicado: (2021)

Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers
por: Orentas, Rimas J., et al.
Publicado: (2012)

c-Jun overexpression in CAR T cells induces exhaustion resistance
por: Lynn, Rachel C., et al.
Publicado: (2019)

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)
por: Walker, Alec, et al.
Publicado: (2014)

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
por: Boyiadzis, Michael M., et al.
Publicado: (2018)

Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014)

IMMU-05. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
por: Mahdi, Jasia, et al.
Publicado: (2023)

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
por: Foster, Jessica B, et al.
Publicado: (2022)

Pediatric Malignancies, Treatment Outcomes and Abandonment of Pediatric Cancer Treatment in Zambia
por: Slone, Jeremy S., et al.
Publicado: (2014)

Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma
por: Long, Adrienne H, et al.
Publicado: (2013)

A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies
por: Rozowsky, Jacob S., et al.
Publicado: (2022)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
por: Fry, Terry J., et al.
Publicado: (2017)

Transient “rest” restores functionality in exhausted CAR-T cells via epigenetic remodeling
por: Weber, Evan W., et al.
Publicado: (2021)

Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies
por: Shalabi, Haneen, et al.
Publicado: (2020)

Clinical Observations and Treatment Approaches for Scoliosis in Prader–Willi Syndrome
por: van Bosse, Harold J.P., et al.
Publicado: (2020)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

Comparison of Food-Based and Music-Based Regulatory Strategies for (Un)Healthy Eating, Depression, Anxiety and Stress
por: Czepczor-Bernat, Kamila, et al.
Publicado: (2021)

Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
por: Avagyan, Serine, et al.
Publicado: (2022)

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
por: Spiegel, Jay Y., et al.
Publicado: (2021)

The Impact of Chemotherapy after Pediatric Malignancy on Humoral Immunity to Vaccine-Preventable Diseases
por: Garonzi, Chiara, et al.
Publicado: (2020)

Communication, on the Impropriety of Plugging Teeth with Two Kinds of Metals in the Same Mouth
por: Mackall, L.
Publicado: (1839)

Novel approaches in treatment of pediatric anxiety
por: Park, Jennifer M., et al.
Publicado: (2014)

Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles
por: Grossmann, Liron D., et al.
Publicado: (2020)

Special Issue: “Pediatric Orthopedic Malignancy: Types, Symptoms, and Treatment”
por: Aiba, Hisaki, et al.
Publicado: (2023)

Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment
por: Spadea, Manuela, et al.
Publicado: (2023)

Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment
por: von Beck, Kelly, et al.
Publicado: (2023)

Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
por: Braun, Till, et al.
Publicado: (2023)

Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
por: Cochran, A. J., et al.
Publicado: (1973)

Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition
por: Alharbi, Bandar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nu0jb7ud0vin3o20nq9o8m32g1